These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 18536695)

  • 1. Technology transfer and idea commercialization.
    Sheft J
    Nat Biotechnol; 2008 Jun; 26(6):711-2. PubMed ID: 18536695
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing biotechnology with a Gallic flair.
    Jouanneau AC
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE36-7. PubMed ID: 12874977
    [No Abstract]   [Full Text] [Related]  

  • 3. Commercializing biotechnology in the UK.
    Searle S; Graves B; Towler C
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE33-5. PubMed ID: 12874976
    [No Abstract]   [Full Text] [Related]  

  • 4. Calling for entrepreneurs: London.
    Smaglik P
    Nat Biotechnol; 2002 Dec; 20(12):1281-2. PubMed ID: 12454679
    [No Abstract]   [Full Text] [Related]  

  • 5. University spin-offs: opportunity or challenge?
    Peng X
    Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioengineering and translational research.
    Kim Y
    IEEE Eng Med Biol Mag; 2005; 24(2):5. PubMed ID: 15825837
    [No Abstract]   [Full Text] [Related]  

  • 7. Biologist aims to ease the pain for entrepreneurs.
    Gewin V
    Nature; 2006 Apr; 440(7085):738-9. PubMed ID: 16598227
    [No Abstract]   [Full Text] [Related]  

  • 8. Who took the tech out of biotech?
    Silverman E
    Nat Biotechnol; 2006 Mar; 24(3):255-6. PubMed ID: 16525373
    [No Abstract]   [Full Text] [Related]  

  • 9. Beyond Bayh-Dole and the Lambert Review: an initial product development and transaction model for the interface between universities and business.
    Fernandes M; Miska D
    Biotechnol Genet Eng Rev; 2004; 21():249-76. PubMed ID: 17017036
    [No Abstract]   [Full Text] [Related]  

  • 10. Incubation without walls.
    Ittelson T; Nelsen L
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE26-7. PubMed ID: 12089582
    [No Abstract]   [Full Text] [Related]  

  • 11. Commercializing nanotechnology.
    Mazzola L
    Nat Biotechnol; 2003 Oct; 21(10):1137-43. PubMed ID: 14520392
    [No Abstract]   [Full Text] [Related]  

  • 12. Biotech knowledge trust.
    Wilan KH
    Nat Biotechnol; 2005 Aug; 23(8):921-3. PubMed ID: 16114122
    [No Abstract]   [Full Text] [Related]  

  • 13. Innovation in Manchester.
    Smith M
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE24-6. PubMed ID: 12089581
    [No Abstract]   [Full Text] [Related]  

  • 14. Asia calls for united approach to commerce.
    Saegusa A
    Nat Biotechnol; 1999 Oct; 17(10):946-7. PubMed ID: 10504685
    [No Abstract]   [Full Text] [Related]  

  • 15. International regional collaborations are paying off.
    Mitchell P
    Nat Biotechnol; 2004 Nov; 22(11):1475. PubMed ID: 15586420
    [No Abstract]   [Full Text] [Related]  

  • 16. Supporting undergraduate biomedical entrepreneurship.
    Patterson PE
    Biomed Sci Instrum; 2004; 40():491-4. PubMed ID: 15134007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investing in nanotechnology.
    Paull R; Wolfe J; Hébert P; Sinkula M
    Nat Biotechnol; 2003 Oct; 21(10):1144-7. PubMed ID: 14520393
    [No Abstract]   [Full Text] [Related]  

  • 18. New biotech hubs may emerge as industry matures.
    Basu P
    Nat Biotechnol; 2003 Oct; 21(10):1123. PubMed ID: 14520385
    [No Abstract]   [Full Text] [Related]  

  • 19. In-licensing as a business model.
    Schafer DP
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE36-9. PubMed ID: 12089585
    [No Abstract]   [Full Text] [Related]  

  • 20. Q&A: Horst Domdey.
    Wald C
    Nature; 2016 May; 533(7601):S30-1. PubMed ID: 27144606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.